These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 1321031)

  • 1. Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins.
    Scheffner M; Münger K; Huibregtse JM; Howley PM
    EMBO J; 1992 Jul; 11(7):2425-31. PubMed ID: 1321031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation.
    Crook T; Tidy JA; Vousden KH
    Cell; 1991 Nov; 67(3):547-56. PubMed ID: 1657399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.
    Huibregtse JM; Scheffner M; Howley PM
    EMBO J; 1991 Dec; 10(13):4129-35. PubMed ID: 1661671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
    Münger K; Scheffner M; Huibregtse JM; Howley PM
    Cancer Surv; 1992; 12():197-217. PubMed ID: 1322242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of p53 DNA binding by human papillomavirus E6 proteins.
    Lechner MS; Laimins LA
    J Virol; 1994 Jul; 68(7):4262-73. PubMed ID: 8207801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
    von Knebel Doeberitz M; Rittmüller C; Aengeneyndt F; Jansen-Dürr P; Spitkovsky D
    J Virol; 1994 May; 68(5):2811-21. PubMed ID: 8151752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein.
    Jones DL; Münger K
    J Virol; 1997 Apr; 71(4):2905-12. PubMed ID: 9060648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development.
    Pan H; Griep AE
    Genes Dev; 1994 Jun; 8(11):1285-99. PubMed ID: 7926731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.
    Scheffner M; Werness BA; Huibregtse JM; Levine AJ; Howley PM
    Cell; 1990 Dec; 63(6):1129-36. PubMed ID: 2175676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phylogenetic and functional analysis of sequence variation of human papillomavirus type 31 E6 and E7 oncoproteins.
    Ferenczi A; Gyöngyösi E; Szalmás A; László B; Kónya J; Veress G
    Infect Genet Evol; 2016 Sep; 43():94-100. PubMed ID: 27197052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
    Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
    Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint.
    Thomas JT; Laimins LA
    J Virol; 1998 Feb; 72(2):1131-7. PubMed ID: 9445009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes.
    Vousden K
    FASEB J; 1993 Jul; 7(10):872-9. PubMed ID: 8393818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins.
    Scheffner M; Takahashi T; Huibregtse JM; Minna JD; Howley PM
    J Virol; 1992 Aug; 66(8):5100-5. PubMed ID: 1321290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain.
    Mansur CP; Marcus B; Dalal S; Androphy EJ
    Oncogene; 1995 Feb; 10(3):457-65. PubMed ID: 7845670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation.
    Li X; Coffino P
    J Virol; 1996 Jul; 70(7):4509-16. PubMed ID: 8676476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.
    Kennedy EM; Kornepati AV; Goldstein M; Bogerd HP; Poling BC; Whisnant AW; Kastan MB; Cullen BR
    J Virol; 2014 Oct; 88(20):11965-72. PubMed ID: 25100830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.
    Wang J; Sampath A; Raychaudhuri P; Bagchi S
    Oncogene; 2001 Aug; 20(34):4740-9. PubMed ID: 11498796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription.
    Lechner MS; Mack DH; Finicle AB; Crook T; Vousden KH; Laimins LA
    EMBO J; 1992 Aug; 11(8):3045-52. PubMed ID: 1379175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.